Fields »
ABOUT
HELP
BLOG

6286 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 126 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
A3GALT2Alpha 1,3-galactosyltransferase 2
Not detected
A4GALTAlpha 1,4-galactosyltransferase
MitochondriaCervical cancer: 2.48e-4
Mixed
AACSAcetoacetyl-CoA synthetase
VesiclesExpressed in all
AADACArylacetamide deacetylase
Ovarian cancer: 5.58e-6
Stomach cancer: 2.19e-4
Pancreatic cancer: 5.02e-4
Group enriched5adrenal gland:151.1
duodenum:187.8
liver:385.8
small intestine:220.5
AADACL2Arylacetamide deacetylase-like 2
Tissue enriched14skin:31.2
AADACL3Arylacetamide deacetylase-like 3
Tissue enhancedplacenta:1.3
AADACL4Arylacetamide deacetylase-like 4N/A
Not detected
AAK1AP2 associated kinase 1
Plasma membrane
Cytosol		Ovarian cancer: 3.19e-4
Tissue enriched6parathyroid gland:382.6
AAMDCAdipogenesis associated, Mth938 domain containing
Nucleoplasm
Cytosol		Expressed in all
AASDHAminoadipate-semialdehyde dehydrogenase
Mixed
AATKApoptosis-associated tyrosine kinase
MitochondriaTissue enhancedcerebral cortex:36.5
duodenum:24.0
ABC7-42404400C24.1
Golgi apparatusTissue enhancedcerebral cortex:13.8
lung:19.5
ABCA1ATP-binding cassette, sub-family A (ABC1), member 1
Nucleoplasm
Vesicles		Mixed
ABCA10ATP-binding cassette, sub-family A (ABC1), member 10
Mixed
ABCA12ATP-binding cassette, sub-family A (ABC1), member 12
Group enriched6breast:7.5
skin:25.3
ABCA13ATP-binding cassette, sub-family A (ABC1), member 13
Vesicles
Centrosome
Cytosol		Tissue enriched10bone marrow:29.4
ABCA2ATP-binding cassette, sub-family A (ABC1), member 2
Tissue enriched6cerebral cortex:98.2
ABCA3ATP-binding cassette, sub-family A (ABC1), member 3
Nucleoplasm
Cytosol		Tissue enhancedlung:135.8
ABCA4ATP-binding cassette, sub-family A (ABC1), member 4
Lung cancer: 2.45e-4
Urothelial cancer: 2.72e-4
Tissue enhancedepididymis:9.7
ABCA5ATP-binding cassette, sub-family A (ABC1), member 5
Pancreatic cancer: 9.97e-5
Expressed in all
ABCA6ATP-binding cassette, sub-family A (ABC1), member 6
NucleoplasmLiver cancer: 3.29e-4
Tissue enhancedliver:41.4
ABCA7ATP-binding cassette, sub-family A (ABC1), member 7
Golgi apparatus
Plasma membrane
Cell Junctions		Endometrial cancer: 1.12e-4
Colorectal cancer: 7.26e-4
Mixed
ABCA8ATP-binding cassette, sub-family A (ABC1), member 8
Nucleoplasm
Cytosol		Mixed
ABCA9ATP-binding cassette, sub-family A (ABC1), member 9
Mixed
ABCB1ATP-binding cassette, sub-family B (MDR/TAP), member 1
Nucleoplasm
Focal adhesion sites
Cytosol		Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedadrenal gland:138.6
small intestine:83.9
ABCB10ATP-binding cassette, sub-family B (MDR/TAP), member 10
Expressed in all
ABCB11ATP-binding cassette, sub-family B (MDR/TAP), member 11
Nucleoplasm
Plasma membrane
Cytosol		Tissue enriched13liver:19.1
ABCB4ATP-binding cassette, sub-family B (MDR/TAP), member 4
Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites		Tissue enriched6liver:69.2
ABCB5ATP-binding cassette, sub-family B (MDR/TAP), member 5N/A
Tissue enriched7epididymis:31.7
ABCB6ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol		Renal cancer: 1.52e-7
Liver cancer: 9.45e-7
Expressed in all
ABCB7ATP-binding cassette, sub-family B (MDR/TAP), member 7
MitochondriaRenal cancer: 5.31e-6
Expressed in all
ABCB8ATP-binding cassette, sub-family B (MDR/TAP), member 8
Nucleus
Mitochondria		Pancreatic cancer: 3.34e-4
Renal cancer: 5.88e-4
Head and neck cancer: 5.91e-4
Expressed in all
ABCB9ATP-binding cassette, sub-family B (MDR/TAP), member 9
VesiclesGlioma: 4.62e-4
Tissue enhancedtestis:23.9
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1
Plasma membraneRenal cancer: 1.55e-6
Liver cancer: 5.42e-5
Mixed
ABCC10ATP-binding cassette, sub-family C (CFTR/MRP), member 10
Renal cancer: 1.90e-4
Expressed in all
ABCC11ATP-binding cassette, sub-family C (CFTR/MRP), member 11
Tissue enriched11breast:63.2
ABCC12ATP-binding cassette, sub-family C (CFTR/MRP), member 12N/A
Tissue enhancedtestis:2.9
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2
Renal cancer: 1.93e-5
Group enriched10duodenum:44.7
gallbladder:42.8
kidney:20.8
liver:67.6
small intestine:50.5
ABCC3ATP-binding cassette, sub-family C (CFTR/MRP), member 3
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
Mixed
ABCC4ATP-binding cassette, sub-family C (CFTR/MRP), member 4
Nucleoli
Plasma membrane
Cytosol		Renal cancer: 2.25e-10
Endometrial cancer: 9.89e-4
Tissue enhancedprostate:68.5
ABCC5ATP-binding cassette, sub-family C (CFTR/MRP), member 5
Nucleus
Plasma membrane
Cell Junctions		Liver cancer: 6.78e-8
Prostate cancer: 3.40e-4
Expressed in all
ABCC6ATP-binding cassette, sub-family C (CFTR/MRP), member 6
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedkidney:15.2
liver:19.1
ABCC8ATP-binding cassette, sub-family C (CFTR/MRP), member 8
Nucleoli
Golgi apparatus
Cytosol		Tissue enhancedcerebral cortex:11.7
ABCC9ATP-binding cassette, sub-family C (CFTR/MRP), member 9
Nucleoplasm
Cytosol		Renal cancer: 1.85e-5
Mixed
ABCD1ATP-binding cassette, sub-family D (ALD), member 1
Renal cancer: 5.50e-4
Expressed in all
ABCD2ATP-binding cassette, sub-family D (ALD), member 2
Tissue enhancedadipose tissue:16.7
ABCD3ATP-binding cassette, sub-family D (ALD), member 3
PeroxisomesColorectal cancer: 1.16e-5
Renal cancer: 4.84e-5
Expressed in all
ABCD4ATP-binding cassette, sub-family D (ALD), member 4
Expressed in all
ABCG1ATP-binding cassette, sub-family G (WHITE), member 1
Golgi apparatus
Vesicles		Renal cancer: 7.16e-6
Expressed in all
ABCG2ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
Nucleus
Plasma membrane		Tissue enhancedsmall intestine:116.1

Page of 126 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.